Article Text
Abstract
Introduction Visibility of tobacco products at retail tobacco outlets is associated with smoking initiation. To address this, across 2020–2022 the Netherlands banned tobacco product displays, advertisements and vending machines in the retail environment. Tobacco/vape specialist shops were exempted. This study assessed the impact of these policies on tobacco visibility in the retail environment and retailer compliance.
Methods We conducted observational audits of all tobacco outlets in four Dutch cities (Amsterdam, Haarlem, Eindhoven and Zwolle) between 2019 and 2022 (before and after policy implementation), assessing visibility of tobacco products and advertisements, compliance and remaining sources of tobacco visibility (after implementation). We described results by location and outlet type.
Results The number of tobacco outlets with any tobacco advertising or product visibility declined from 530 to 267 (−50%). Among outlets not exempt from the ban, the number with visibility declined from 449 to 172 (−62%), with lower postban visibility in petrol stations (12%) and supermarkets (6%) than small shops (47%). Visibility among tobacco/vape shops increased by 17%. Tobacco product displays remained the main source of visibility. 93% of tobacco vending machines were removed. Maps showed that non-compliance is concentrated in Amsterdam’s city centre and more evenly distributed in other cities.
Conclusion The bans on tobacco display and tobacco advertising halved the visibility of tobacco in the retail environment, and the vending machine ban practically eradicated vending machines. To further reduce tobacco visibility, violations in small shops should be addressed and tobacco visibility should be regulated in currently exempt tobacco specialist shops.
- Denormalization
- Public policy
- Surveillance and monitoring
Data availability statement
Data are available upon reasonable request. Audit data are available from the authors upon reasonable request. Please contact m.a.kuipers@amsterdamumc.nl for more information.
Statistics from Altmetric.com
Data availability statement
Data are available upon reasonable request. Audit data are available from the authors upon reasonable request. Please contact m.a.kuipers@amsterdamumc.nl for more information.
Footnotes
Contributors MK, TvD and AK conceptualised and designed this paper. MK and TvD organised and coordinated observational audit data collection. MB and TvD prepared the data. MB executed the analysis and drafted the initial manuscript. MK, TvD, BvdP and AK reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. MB was responsible for the overall content and is the guarantor of this paper.
Funding This study is part of the ‘Tobacco out of Sight’ project, which is funded by the Dutch Lung Foundation, Dutch Heart Foundation, Dutch Cancer Society, Dutch Thrombosis Foundation and Dutch Diabetes research Foundation, Call tobacco control policies 2018, under project number 2.1.19.007.
Map disclaimer The depiction of boundaries on this map does not imply the expression of any opinion whatsoever on the part of BMJ (or any member of its group) concerning the legal status of any country, territory, jurisdiction or area or of its authorities. This map is provided without any warranty of any kind, either express or implied.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.